Share Price and Basic Stock Data
Last Updated: October 9, 2025, 1:11 am
| PEG Ratio | 0.32 |
|---|
Analyst Insight & Comprehensive Analysis
Frontline Corporation Ltd, a road transport company, currently trades at a price of ₹39.7 with a market capitalization of ₹19.9 Cr. The company’s low P/E ratio of 6.47 indicates an undervalued position compared to the sector average, suggesting potential for capital appreciation. With a respectable ROE of 14.6% and a ROCE of 4.73%, Frontline Corporation demonstrates efficient capital utilization despite the challenging operating environment, as reflected by a modest OPM of 2.51%. Furthermore, the company’s healthy Interest Coverage Ratio (ICR) of 7.88x indicates a comfortable ability to service its debt obligations. The presence of strong promoter holding at 47.57% underscores confidence in the company’s prospects.
However, Frontline Corporation faces risks stemming from its high level of borrowings amounting to ₹57 Cr, which may elevate financial leverage and interest rate sensitivity, particularly in a rising rate environment. The company’s relatively low Net Profit of ₹3 Cr suggests limited bottom-line growth potential, necessitating a focus on operational efficiency and revenue diversification. Looking ahead, improving operational efficiency and diversifying revenue streams beyond traditional road transport services could enhance Frontline Corporation’s resilience and competitiveness in a dynamic market landscape. For investors, closely monitoring the company’s debt management and profitability metrics will be crucial in assessing its long-term sustainability and growth trajectory.
In conclusion, while Frontline Corporation Ltd exhibits certain financial strengths such as solid ROE and promoter confidence, mitigating risks associated with high debt levels and stagnant profitability will be key to unlocking its full potential and ensuring sustainable value creation for shareholders in the long run.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Frontline Corporation Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Frontline Corporation Ltd | 19.8 Cr. | 39.7 | 61.5/37.4 | 6.47 | 30.8 | 0.00 % | 4.73 % | 14.6 % | 10.0 |
| Coastal Roadways Ltd | 16.4 Cr. | 39.5 | 45.6/29.0 | 10.3 | 56.4 | 0.00 % | 9.25 % | 6.35 % | 10.0 |
| Balurghat Technologies Ltd | 30.1 Cr. | 16.6 | 41.5/15.6 | 29.2 | 9.56 | 0.00 % | 13.0 % | 12.7 % | 10.0 |
| ABC India Ltd | 45.7 Cr. | 84.4 | 139/78.1 | 26.7 | 101 | 0.59 % | 6.57 % | 4.15 % | 10.0 |
| Transport Corporation of India Ltd (TCI) | 9,381 Cr. | 1,202 | 1,309/875 | 21.9 | 276 | 0.67 % | 20.5 % | 19.8 % | 2.00 |
| Industry Average | 2,529.00 Cr | 179.27 | 28.73 | 116.13 | 0.14% | 11.99% | 10.77% | 9.11 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 20.95 | 15.56 | 19.60 | 20.56 | 22.84 | 21.27 | 21.18 | 22.56 | 24.86 | 25.26 | 25.34 | 28.50 | 31.49 |
| Expenses | 20.73 | 15.00 | 18.64 | 21.48 | 22.82 | 20.94 | 21.02 | 23.02 | 24.43 | 24.58 | 24.56 | 28.14 | 30.70 |
| Operating Profit | 0.22 | 0.56 | 0.96 | -0.92 | 0.02 | 0.33 | 0.16 | -0.46 | 0.43 | 0.68 | 0.78 | 0.36 | 0.79 |
| OPM % | 1.05% | 3.60% | 4.90% | -4.47% | 0.09% | 1.55% | 0.76% | -2.04% | 1.73% | 2.69% | 3.08% | 1.26% | 2.51% |
| Other Income | 0.76 | 0.70 | 0.73 | 2.22 | 0.73 | 0.79 | 0.87 | 0.96 | 0.78 | 1.07 | 0.81 | 1.70 | 0.73 |
| Interest | 0.01 | 0.01 | 0.01 | 0.08 | 0.01 | 0.01 | 0.02 | 0.18 | 0.21 | 0.20 | 0.18 | 0.25 | 0.22 |
| Depreciation | 0.38 | 0.39 | 0.41 | 0.42 | 0.42 | 0.42 | 0.38 | 0.38 | 0.47 | 0.49 | 0.49 | 0.74 | 0.56 |
| Profit before tax | 0.59 | 0.86 | 1.27 | 0.80 | 0.32 | 0.69 | 0.63 | -0.06 | 0.53 | 1.06 | 0.92 | 1.07 | 0.74 |
| Tax % | 25.42% | 23.26% | 24.41% | 21.25% | 59.38% | 37.68% | 34.92% | -533.33% | 28.30% | 13.21% | 23.91% | 17.76% | 22.97% |
| Net Profit | 0.44 | 0.67 | 0.97 | 0.63 | 0.14 | 0.42 | 0.41 | 0.25 | 0.39 | 0.91 | 0.71 | 0.88 | 0.57 |
| EPS in Rs | 0.88 | 1.34 | 1.94 | 1.26 | 0.28 | 0.84 | 0.82 | 0.50 | 0.78 | 1.82 | 1.42 | 1.76 | 1.14 |
Last Updated: August 19, 2025, 3:10 pm
Below is a detailed analysis of the quarterly data for Frontline Corporation Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 31.49 Cr.. The value appears strong and on an upward trend. It has increased from 28.50 Cr. (Mar 2025) to 31.49 Cr., marking an increase of 2.99 Cr..
- For Expenses, as of Jun 2025, the value is 30.70 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 28.14 Cr. (Mar 2025) to 30.70 Cr., marking an increase of 2.56 Cr..
- For Operating Profit, as of Jun 2025, the value is 0.79 Cr.. The value appears strong and on an upward trend. It has increased from 0.36 Cr. (Mar 2025) to 0.79 Cr., marking an increase of 0.43 Cr..
- For OPM %, as of Jun 2025, the value is 2.51%. The value appears strong and on an upward trend. It has increased from 1.26% (Mar 2025) to 2.51%, marking an increase of 1.25%.
- For Other Income, as of Jun 2025, the value is 0.73 Cr.. The value appears to be declining and may need further review. It has decreased from 1.70 Cr. (Mar 2025) to 0.73 Cr., marking a decrease of 0.97 Cr..
- For Interest, as of Jun 2025, the value is 0.22 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.25 Cr. (Mar 2025) to 0.22 Cr., marking a decrease of 0.03 Cr..
- For Depreciation, as of Jun 2025, the value is 0.56 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.74 Cr. (Mar 2025) to 0.56 Cr., marking a decrease of 0.18 Cr..
- For Profit before tax, as of Jun 2025, the value is 0.74 Cr.. The value appears to be declining and may need further review. It has decreased from 1.07 Cr. (Mar 2025) to 0.74 Cr., marking a decrease of 0.33 Cr..
- For Tax %, as of Jun 2025, the value is 22.97%. The value appears to be increasing, which may not be favorable. It has increased from 17.76% (Mar 2025) to 22.97%, marking an increase of 5.21%.
- For Net Profit, as of Jun 2025, the value is 0.57 Cr.. The value appears to be declining and may need further review. It has decreased from 0.88 Cr. (Mar 2025) to 0.57 Cr., marking a decrease of 0.31 Cr..
- For EPS in Rs, as of Jun 2025, the value is 1.14. The value appears to be declining and may need further review. It has decreased from 1.76 (Mar 2025) to 1.14, marking a decrease of 0.62.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: June 16, 2025, 1:24 pm
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 42 | 38 | 38 | 43 | 44 | 47 | 48 | 59 | 72 | 77 | 88 | 104 |
| Expenses | 40 | 36 | 38 | 46 | 44 | 47 | 50 | 58 | 71 | 76 | 88 | 102 |
| Operating Profit | 2 | 1 | 0 | -2 | -0 | -1 | -2 | 1 | 0 | 1 | 0 | 2 |
| OPM % | 5% | 3% | 1% | -5% | -0% | -1% | -4% | 1% | 0% | 1% | 0% | 2% |
| Other Income | 4 | 3 | 1 | 10 | 4 | 3 | 3 | 3 | 4 | 4 | 3 | 4 |
| Interest | 6 | 5 | 5 | 5 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 1 |
| Depreciation | 2 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
| Profit before tax | -1 | -2 | -5 | 1 | 2 | -1 | -1 | 1 | 2 | 4 | 2 | 4 |
| Tax % | -87% | -11% | -18% | 33% | 17% | -35% | -16% | 12% | 21% | 23% | 22% | 19% |
| Net Profit | -0 | -2 | -4 | 1 | 2 | -0 | -1 | 1 | 1 | 3 | 1 | 3 |
| EPS in Rs | -0.34 | -3.66 | -8.50 | 1.70 | 3.84 | -0.66 | -1.98 | 2.30 | 2.90 | 5.42 | 2.44 | 5.78 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
YoY Net Profit Growth
| Year | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -100.00% | 125.00% | 100.00% | -100.00% | 200.00% | 0.00% | 200.00% | -66.67% | 200.00% |
| Change in YoY Net Profit Growth (%) | 0.00% | 225.00% | -25.00% | -200.00% | 300.00% | -200.00% | 200.00% | -266.67% | 266.67% |
Frontline Corporation Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 9 years from 2015-2016 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 11% |
| 5 Years: | 16% |
| 3 Years: | 13% |
| TTM: | 23% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 11% |
| 5 Years: | 32% |
| 3 Years: | 12% |
| TTM: | 109% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | 34% |
| 3 Years: | 40% |
| 1 Year: | -3% |
| Return on Equity | |
|---|---|
| 10 Years: | 4% |
| 5 Years: | 15% |
| 3 Years: | 14% |
| Last Year: | 15% |
Last Updated: September 5, 2025, 3:30 pm
Balance Sheet
Last Updated: July 25, 2025, 1:17 pm
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 |
| Reserves | 7 | 5 | 1 | 0 | 2 | 2 | 1 | 2 | 4 | 6 | 8 | 10 |
| Borrowings | 38 | 45 | 39 | 51 | 54 | 53 | 53 | 52 | 49 | 49 | 57 | 57 |
| Other Liabilities | 24 | 19 | 32 | 17 | 15 | 15 | 10 | 6 | 6 | 6 | 8 | 9 |
| Total Liabilities | 74 | 73 | 77 | 73 | 77 | 75 | 68 | 65 | 63 | 66 | 77 | 82 |
| Fixed Assets | 27 | 26 | 28 | 32 | 35 | 33 | 34 | 32 | 31 | 30 | 34 | 35 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 2 | 0 |
| Investments | 7 | 7 | 7 | 0 | 0 | 0 | 0 | 1 | 1 | 2 | 1 | 0 |
| Other Assets | 40 | 40 | 42 | 40 | 41 | 41 | 35 | 32 | 32 | 34 | 40 | 46 |
| Total Assets | 74 | 73 | 77 | 73 | 77 | 75 | 68 | 65 | 63 | 66 | 77 | 82 |
Below is a detailed analysis of the balance sheet data for Frontline Corporation Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Equity Capital, as of Mar 2025, the value is 5.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 5.00 Cr..
- For Reserves, as of Mar 2025, the value is 10.00 Cr.. The value appears strong and on an upward trend. It has increased from 8.00 Cr. (Mar 2024) to 10.00 Cr., marking an increase of 2.00 Cr..
- For Borrowings, as of Mar 2025, the value is 57.00 Cr.. The value remains steady. However, Borrowings exceed Reserves, which may signal higher financial risk. There is no change compared to the previous period (Mar 2024) which recorded 57.00 Cr..
- For Other Liabilities, as of Mar 2025, the value is 9.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 8.00 Cr. (Mar 2024) to 9.00 Cr., marking an increase of 1.00 Cr..
- For Total Liabilities, as of Mar 2025, the value is 82.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 77.00 Cr. (Mar 2024) to 82.00 Cr., marking an increase of 5.00 Cr..
- For Fixed Assets, as of Mar 2025, the value is 35.00 Cr.. The value appears strong and on an upward trend. It has increased from 34.00 Cr. (Mar 2024) to 35.00 Cr., marking an increase of 1.00 Cr..
- For CWIP, as of Mar 2025, the value is 0.00 Cr.. The value appears to be declining and may need further review. It has decreased from 2.00 Cr. (Mar 2024) to 0.00 Cr., marking a decrease of 2.00 Cr..
- For Investments, as of Mar 2025, the value is 0.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1.00 Cr. (Mar 2024) to 0.00 Cr., marking a decrease of 1.00 Cr..
- For Other Assets, as of Mar 2025, the value is 46.00 Cr.. The value appears strong and on an upward trend. It has increased from 40.00 Cr. (Mar 2024) to 46.00 Cr., marking an increase of 6.00 Cr..
- For Total Assets, as of Mar 2025, the value is 82.00 Cr.. The value appears strong and on an upward trend. It has increased from 77.00 Cr. (Mar 2024) to 82.00 Cr., marking an increase of 5.00 Cr..
However, the Borrowings (57.00 Cr.) are higher than the Reserves (10.00 Cr.), which may signal higher financial risk.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -36.00 | -44.00 | -39.00 | -53.00 | -54.00 | -54.00 | -55.00 | -51.00 | -49.00 | -48.00 | -57.00 | -55.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 75 | 74 | 66 | 77 | 82 | 66 | 57 | 57 | 42 | 39 | 38 | 39 |
| Inventory Days | 169 | 213 | 208 | 130 | 141 | 142 | 88 | 40 | 35 | 47 | 48 | 53 |
| Days Payable | 242 | 200 | 64 | 203 | 216 | 192 | 100 | 38 | 24 | 24 | 28 | 32 |
| Cash Conversion Cycle | 1 | 86 | 209 | 4 | 7 | 16 | 45 | 59 | 53 | 61 | 59 | 60 |
| Working Capital Days | -291 | -365 | -348 | -273 | -246 | -237 | -252 | -204 | -161 | -147 | -136 | -108 |
| ROCE % | 4% | 5% | 0% | 11% | 4% | -0% | -1% | 3% | 4% | 4% | 2% | 5% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 5.80 | 2.44 | 5.44 | 2.91 | 2.30 |
| Diluted EPS (Rs.) | 5.80 | 2.44 | 5.44 | 2.91 | 2.30 |
| Cash EPS (Rs.) | 10.21 | 5.67 | 8.65 | 6.43 | 6.34 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 30.92 | 25.11 | 22.77 | 17.25 | 14.36 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 30.92 | 25.11 | 22.77 | 17.25 | 14.36 |
| Revenue From Operations / Share (Rs.) | 208.85 | 176.49 | 154.04 | 144.14 | 117.74 |
| PBDIT / Share (Rs.) | 13.28 | 6.83 | 10.51 | 7.78 | 7.51 |
| PBIT / Share (Rs.) | 8.87 | 3.59 | 7.30 | 4.26 | 3.47 |
| PBT / Share (Rs.) | 7.18 | 3.15 | 7.09 | 3.70 | 2.62 |
| Net Profit / Share (Rs.) | 5.80 | 2.44 | 5.44 | 2.91 | 2.30 |
| PBDIT Margin (%) | 6.35 | 3.86 | 6.82 | 5.39 | 6.37 |
| PBIT Margin (%) | 4.24 | 2.03 | 4.74 | 2.95 | 2.94 |
| PBT Margin (%) | 3.44 | 1.78 | 4.59 | 2.56 | 2.22 |
| Net Profit Margin (%) | 2.77 | 1.38 | 3.53 | 2.02 | 1.95 |
| Return on Networth / Equity (%) | 18.77 | 9.72 | 23.90 | 16.88 | 16.04 |
| Return on Capital Employeed (%) | 19.51 | 8.43 | 29.19 | 23.00 | 17.80 |
| Return On Assets (%) | 3.52 | 1.57 | 4.07 | 2.28 | 1.77 |
| Long Term Debt / Equity (X) | 0.47 | 0.69 | 0.09 | 0.07 | 0.35 |
| Total Debt / Equity (X) | 3.72 | 4.56 | 4.34 | 5.69 | 7.08 |
| Asset Turnover Ratio (%) | 1.31 | 1.22 | 1.18 | 1.12 | 0.88 |
| Current Ratio (X) | 0.51 | 0.54 | 0.48 | 0.44 | 0.44 |
| Quick Ratio (X) | 0.33 | 0.38 | 0.35 | 0.35 | 0.36 |
| Interest Coverage Ratio (X) | 7.88 | 15.24 | 48.34 | 13.75 | 8.86 |
| Interest Coverage Ratio (Post Tax) (X) | 4.44 | 6.45 | 26.04 | 6.15 | 3.72 |
| Enterprise Value (Cr.) | 76.12 | 75.35 | 60.46 | 61.41 | 54.17 |
| EV / Net Operating Revenue (X) | 0.73 | 0.85 | 0.78 | 0.85 | 0.92 |
| EV / EBITDA (X) | 11.52 | 22.18 | 11.56 | 15.87 | 14.49 |
| MarketCap / Net Operating Revenue (X) | 0.19 | 0.21 | 0.15 | 0.18 | 0.08 |
| Price / BV (X) | 1.33 | 1.55 | 1.07 | 1.57 | 0.67 |
| Price / Net Operating Revenue (X) | 0.19 | 0.21 | 0.15 | 0.18 | 0.08 |
| EarningsYield | 0.14 | 0.06 | 0.22 | 0.10 | 0.23 |
After reviewing the key financial ratios for Frontline Corporation Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 5.80. This value is within the healthy range. It has increased from 2.44 (Mar 24) to 5.80, marking an increase of 3.36.
- For Diluted EPS (Rs.), as of Mar 25, the value is 5.80. This value is within the healthy range. It has increased from 2.44 (Mar 24) to 5.80, marking an increase of 3.36.
- For Cash EPS (Rs.), as of Mar 25, the value is 10.21. This value is within the healthy range. It has increased from 5.67 (Mar 24) to 10.21, marking an increase of 4.54.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 30.92. It has increased from 25.11 (Mar 24) to 30.92, marking an increase of 5.81.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 30.92. It has increased from 25.11 (Mar 24) to 30.92, marking an increase of 5.81.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 208.85. It has increased from 176.49 (Mar 24) to 208.85, marking an increase of 32.36.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 13.28. This value is within the healthy range. It has increased from 6.83 (Mar 24) to 13.28, marking an increase of 6.45.
- For PBIT / Share (Rs.), as of Mar 25, the value is 8.87. This value is within the healthy range. It has increased from 3.59 (Mar 24) to 8.87, marking an increase of 5.28.
- For PBT / Share (Rs.), as of Mar 25, the value is 7.18. This value is within the healthy range. It has increased from 3.15 (Mar 24) to 7.18, marking an increase of 4.03.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 5.80. This value is within the healthy range. It has increased from 2.44 (Mar 24) to 5.80, marking an increase of 3.36.
- For PBDIT Margin (%), as of Mar 25, the value is 6.35. This value is below the healthy minimum of 10. It has increased from 3.86 (Mar 24) to 6.35, marking an increase of 2.49.
- For PBIT Margin (%), as of Mar 25, the value is 4.24. This value is below the healthy minimum of 10. It has increased from 2.03 (Mar 24) to 4.24, marking an increase of 2.21.
- For PBT Margin (%), as of Mar 25, the value is 3.44. This value is below the healthy minimum of 10. It has increased from 1.78 (Mar 24) to 3.44, marking an increase of 1.66.
- For Net Profit Margin (%), as of Mar 25, the value is 2.77. This value is below the healthy minimum of 5. It has increased from 1.38 (Mar 24) to 2.77, marking an increase of 1.39.
- For Return on Networth / Equity (%), as of Mar 25, the value is 18.77. This value is within the healthy range. It has increased from 9.72 (Mar 24) to 18.77, marking an increase of 9.05.
- For Return on Capital Employeed (%), as of Mar 25, the value is 19.51. This value is within the healthy range. It has increased from 8.43 (Mar 24) to 19.51, marking an increase of 11.08.
- For Return On Assets (%), as of Mar 25, the value is 3.52. This value is below the healthy minimum of 5. It has increased from 1.57 (Mar 24) to 3.52, marking an increase of 1.95.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.47. This value is within the healthy range. It has decreased from 0.69 (Mar 24) to 0.47, marking a decrease of 0.22.
- For Total Debt / Equity (X), as of Mar 25, the value is 3.72. This value exceeds the healthy maximum of 1. It has decreased from 4.56 (Mar 24) to 3.72, marking a decrease of 0.84.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 1.31. It has increased from 1.22 (Mar 24) to 1.31, marking an increase of 0.09.
- For Current Ratio (X), as of Mar 25, the value is 0.51. This value is below the healthy minimum of 1.5. It has decreased from 0.54 (Mar 24) to 0.51, marking a decrease of 0.03.
- For Quick Ratio (X), as of Mar 25, the value is 0.33. This value is below the healthy minimum of 1. It has decreased from 0.38 (Mar 24) to 0.33, marking a decrease of 0.05.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 7.88. This value is within the healthy range. It has decreased from 15.24 (Mar 24) to 7.88, marking a decrease of 7.36.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 4.44. This value is within the healthy range. It has decreased from 6.45 (Mar 24) to 4.44, marking a decrease of 2.01.
- For Enterprise Value (Cr.), as of Mar 25, the value is 76.12. It has increased from 75.35 (Mar 24) to 76.12, marking an increase of 0.77.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.73. This value is below the healthy minimum of 1. It has decreased from 0.85 (Mar 24) to 0.73, marking a decrease of 0.12.
- For EV / EBITDA (X), as of Mar 25, the value is 11.52. This value is within the healthy range. It has decreased from 22.18 (Mar 24) to 11.52, marking a decrease of 10.66.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.19. This value is below the healthy minimum of 1. It has decreased from 0.21 (Mar 24) to 0.19, marking a decrease of 0.02.
- For Price / BV (X), as of Mar 25, the value is 1.33. This value is within the healthy range. It has decreased from 1.55 (Mar 24) to 1.33, marking a decrease of 0.22.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.19. This value is below the healthy minimum of 1. It has decreased from 0.21 (Mar 24) to 0.19, marking a decrease of 0.02.
- For EarningsYield, as of Mar 25, the value is 0.14. This value is below the healthy minimum of 5. It has increased from 0.06 (Mar 24) to 0.14, marking an increase of 0.08.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Frontline Corporation Ltd:
- Net Profit Margin: 2.77%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 19.51% (Industry Average ROCE: 11.99%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 18.77% (Industry Average ROE: 10.77%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 4.44
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.33
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 6.47 (Industry average Stock P/E: 28.73)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 3.72
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 2.77%
About the Company - Qualitative Analysis
Frontline Corporation Ltd. is a Public Limited Listed company incorporated on 04/12/1989 and has its registered office in the State of West Bengal, India. Company's Corporate Identification Number(CIN) is L63090WB1989PLC099645 and registration number is 013078. Currently Company is involved in the business activities of Air transport. Company's Total Operating Revenue is Rs. 103.96 Cr. and Equity Capital is Rs. 4.98 Cr. for the Year ended 31/03/2025.
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Transport - Road | 4, B.B.D Bag (East), Stephen House, Kolkata West Bengal 700001 | frontlinecorplimited@gmail.com http://www.frontlinecorporation.org |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Ram Prasad Agarwal | Chairman & Director |
| Mr. Pawan Kumar Agarwal | Managing Director |
| Mr. Narayan Prasad Agarwal | Director |
| Mr. Saurabh Jhunjhunwala | Director |
| Mrs. Dipika Pradeep Soni | Independent Woman Director |
| Mr. Dipen Ashit Dalal | Independent Director |
| Ms. Aarefa Kutub Kapasi | Independent Woman Director |
| Mrs. Ummay Amen Mashraqi | Independent Woman Director |
FAQ
What is the intrinsic value of Frontline Corporation Ltd?
Frontline Corporation Ltd's intrinsic value (as of 10 October 2025) is 23.74 which is 40.20% lower the current market price of 39.70, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹19.8 Cr. market cap, FY2025-2026 high/low of 61.5/37.4, reserves of ₹10 Cr, and liabilities of 82 Cr.
What is the Market Cap of Frontline Corporation Ltd?
The Market Cap of Frontline Corporation Ltd is 19.8 Cr..
What is the current Stock Price of Frontline Corporation Ltd as on 10 October 2025?
The current stock price of Frontline Corporation Ltd as on 10 October 2025 is 39.7.
What is the High / Low of Frontline Corporation Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Frontline Corporation Ltd stocks is 61.5/37.4.
What is the Stock P/E of Frontline Corporation Ltd?
The Stock P/E of Frontline Corporation Ltd is 6.47.
What is the Book Value of Frontline Corporation Ltd?
The Book Value of Frontline Corporation Ltd is 30.8.
What is the Dividend Yield of Frontline Corporation Ltd?
The Dividend Yield of Frontline Corporation Ltd is 0.00 %.
What is the ROCE of Frontline Corporation Ltd?
The ROCE of Frontline Corporation Ltd is 4.73 %.
What is the ROE of Frontline Corporation Ltd?
The ROE of Frontline Corporation Ltd is 14.6 %.
What is the Face Value of Frontline Corporation Ltd?
The Face Value of Frontline Corporation Ltd is 10.0.